EE9700202A - Diasendatud 1,4-piperidiini estrid ja amiidid, mis omavad 5-HT4 antagonistlikku aktiivsust - Google Patents
Diasendatud 1,4-piperidiini estrid ja amiidid, mis omavad 5-HT4 antagonistlikku aktiivsustInfo
- Publication number
- EE9700202A EE9700202A EE9700202A EE9700202A EE9700202A EE 9700202 A EE9700202 A EE 9700202A EE 9700202 A EE9700202 A EE 9700202A EE 9700202 A EE9700202 A EE 9700202A EE 9700202 A EE9700202 A EE 9700202A
- Authority
- EE
- Estonia
- Prior art keywords
- disubstituted
- amides
- antagonist activity
- piperidine esters
- piperidine
- Prior art date
Links
- FUFZNHHSSMCXCZ-UHFFFAOYSA-N 5-piperidin-4-yl-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole Chemical class FC(F)(F)C1=CC=CC(C=2N=C(ON=2)C2CCNCC2)=C1 FUFZNHHSSMCXCZ-UHFFFAOYSA-N 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
- 239000003523 serotonin 4 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI000491A IT1275903B1 (it) | 1995-03-14 | 1995-03-14 | Esteri e ammidi della 1,4-piperidina disostituita |
| PCT/EP1996/000903 WO1996028424A1 (en) | 1995-03-14 | 1996-03-04 | Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9700202A true EE9700202A (et) | 1998-02-16 |
Family
ID=11370883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9700202A EE9700202A (et) | 1995-03-14 | 1996-03-04 | Diasendatud 1,4-piperidiini estrid ja amiidid, mis omavad 5-HT4 antagonistlikku aktiivsust |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6002009A (de) |
| EP (1) | EP0815080B1 (de) |
| JP (1) | JP4021477B2 (de) |
| KR (1) | KR19980702972A (de) |
| AR (1) | AR002967A1 (de) |
| AT (1) | ATE269304T1 (de) |
| AU (1) | AU5101096A (de) |
| BG (1) | BG101711A (de) |
| BR (1) | BR9607347A (de) |
| CA (1) | CA2209904C (de) |
| CO (1) | CO4700521A1 (de) |
| CZ (1) | CZ285997A3 (de) |
| DE (1) | DE69632724T2 (de) |
| EE (1) | EE9700202A (de) |
| ES (1) | ES2224159T3 (de) |
| HR (1) | HRP960116A2 (de) |
| IL (1) | IL117446A0 (de) |
| IT (1) | IT1275903B1 (de) |
| NO (1) | NO974236D0 (de) |
| NZ (1) | NZ303941A (de) |
| PE (1) | PE7698A1 (de) |
| PL (1) | PL322211A1 (de) |
| SK (1) | SK121397A3 (de) |
| TR (1) | TR199700948T1 (de) |
| WO (1) | WO1996028424A1 (de) |
| YU (1) | YU14196A (de) |
| ZA (1) | ZA962009B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT832065E (pt) * | 1995-06-06 | 2002-02-28 | Pfizer | N-(indole-2-carbonil)-glicinamidas e seus derivados como agentes antidiabeticos |
| AU7001796A (en) * | 1995-09-22 | 1997-04-09 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and medicinal use thereof |
| TW445263B (en) | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
| IL125658A0 (en) | 1997-08-18 | 1999-04-11 | Hoffmann La Roche | Ccr-3 receptor antagonists |
| US6339087B1 (en) | 1997-08-18 | 2002-01-15 | Syntex (U.S.A.) Llc | Cyclic amine derivatives-CCR-3 receptor antagonists |
| TW570920B (en) | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
| GB0211230D0 (en) * | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
| PL1664036T3 (pl) * | 2003-09-03 | 2012-04-30 | Pfizer | Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4 |
| TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
| US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
| US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
| EA200801607A1 (ru) * | 2004-06-15 | 2008-10-30 | Пфайзер Инк. | Производные бензимидазолонкарбоновой кислоты |
| AP2418A (en) * | 2004-06-15 | 2012-06-04 | Pfizer | Benzimidazolone carboxylic acid derivatives. |
| JP2008509088A (ja) * | 2004-09-02 | 2008-03-27 | ファイザー株式会社 | ベンズイミダゾロンカルボン酸誘導体 |
| DE602005016446D1 (de) * | 2004-11-05 | 2009-10-15 | Theravance Inc | 5-HT4-Rezeptoragonistenverbindungen |
| DE602005014566D1 (de) * | 2004-11-05 | 2009-07-02 | Theravance Inc | Chinolinon-carboxamid-verbindungen |
| ATE469897T1 (de) * | 2004-12-22 | 2010-06-15 | Theravance Inc | Indazolcarbonsäureamidverbindungen |
| AU2006217534B8 (en) * | 2005-02-22 | 2011-12-08 | Pfizer Inc. | Oxyindole derivatives as 5HT4 receptor agonists |
| BRPI0608392A2 (pt) * | 2005-03-02 | 2009-12-29 | Theravance Inc | compostos de quinolinona como agonistas do receptor 5-ht4 |
| US7317022B2 (en) * | 2005-06-07 | 2008-01-08 | Theravance, Inc. | Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists |
| MY143574A (en) * | 2005-11-22 | 2011-05-31 | Theravance Inc | Carbamate compounds as 5-ht4 receptor agonists |
| US8642772B2 (en) * | 2008-10-14 | 2014-02-04 | Sk Biopharmaceuticals Co., Ltd. | Piperidine compounds, pharmaceutical composition comprising the same and its use |
| US8232315B2 (en) * | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| ES2447295T3 (es) | 2009-11-06 | 2014-03-11 | Sk Biopharmaceuticals Co., Ltd. | Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad |
| EP2496227B1 (de) | 2009-11-06 | 2019-05-22 | SK Biopharmaceuticals Co., Ltd. | Verfahren zur behandlung des fibromyalgie-syndroms |
| NZ604423A (en) | 2010-06-24 | 2015-01-30 | Alkermes Pharma Ireland Ltd | Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
| GB9204565D0 (en) * | 1992-03-03 | 1992-04-15 | Smithkline Beecham Plc | Pharmaceuticals |
| WO1994008965A1 (en) * | 1992-10-16 | 1994-04-28 | Smithkline Beecham Plc | N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists |
| KR970702247A (ko) * | 1994-03-30 | 1997-05-13 | 고야 마사시 | 벤조산 화합물 및 이들의 약제로서의 용도(benzoic acid compound and use thereof as medicine) |
-
1995
- 1995-03-14 IT IT95MI000491A patent/IT1275903B1/it active IP Right Grant
-
1996
- 1996-03-04 CZ CZ972859A patent/CZ285997A3/cs unknown
- 1996-03-04 ES ES96907342T patent/ES2224159T3/es not_active Expired - Lifetime
- 1996-03-04 EP EP96907342A patent/EP0815080B1/de not_active Expired - Lifetime
- 1996-03-04 KR KR1019970706380A patent/KR19980702972A/ko not_active Withdrawn
- 1996-03-04 WO PCT/EP1996/000903 patent/WO1996028424A1/en not_active Ceased
- 1996-03-04 PL PL96322211A patent/PL322211A1/xx unknown
- 1996-03-04 BR BR9607347A patent/BR9607347A/pt not_active Application Discontinuation
- 1996-03-04 NZ NZ303941A patent/NZ303941A/en unknown
- 1996-03-04 CA CA002209904A patent/CA2209904C/en not_active Expired - Lifetime
- 1996-03-04 TR TR97/00948T patent/TR199700948T1/xx unknown
- 1996-03-04 US US08/913,425 patent/US6002009A/en not_active Expired - Lifetime
- 1996-03-04 JP JP52723396A patent/JP4021477B2/ja not_active Expired - Lifetime
- 1996-03-04 AU AU51010/96A patent/AU5101096A/en not_active Abandoned
- 1996-03-04 AT AT96907342T patent/ATE269304T1/de active
- 1996-03-04 SK SK1213-97A patent/SK121397A3/sk unknown
- 1996-03-04 DE DE69632724T patent/DE69632724T2/de not_active Expired - Lifetime
- 1996-03-04 EE EE9700202A patent/EE9700202A/xx unknown
- 1996-03-05 PE PE1996000151A patent/PE7698A1/es not_active Application Discontinuation
- 1996-03-08 AR ARP960101670A patent/AR002967A1/es unknown
- 1996-03-11 YU YU14196A patent/YU14196A/sh unknown
- 1996-03-12 IL IL11744696A patent/IL117446A0/xx unknown
- 1996-03-13 ZA ZA9602009A patent/ZA962009B/xx unknown
- 1996-03-13 CO CO96012408A patent/CO4700521A1/es unknown
- 1996-03-13 HR HRMI95A000491A patent/HRP960116A2/hr not_active Application Discontinuation
-
1997
- 1997-07-01 BG BG101711A patent/BG101711A/xx unknown
- 1997-09-12 NO NO974236A patent/NO974236D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ITMI950491A0 (it) | 1995-03-14 |
| IL117446A0 (en) | 1996-07-23 |
| TR199700948T1 (xx) | 1998-03-21 |
| NO974236L (no) | 1997-09-12 |
| PL322211A1 (en) | 1998-01-19 |
| CA2209904C (en) | 2007-11-13 |
| AU5101096A (en) | 1996-10-02 |
| JPH11501640A (ja) | 1999-02-09 |
| CZ285997A3 (cs) | 1998-02-18 |
| ATE269304T1 (de) | 2004-07-15 |
| HRP960116A2 (en) | 1997-10-31 |
| US6002009A (en) | 1999-12-14 |
| KR19980702972A (ko) | 1998-09-05 |
| JP4021477B2 (ja) | 2007-12-12 |
| ZA962009B (en) | 1997-09-15 |
| EP0815080B1 (de) | 2004-06-16 |
| NO974236D0 (no) | 1997-09-12 |
| NZ303941A (en) | 1998-11-25 |
| ES2224159T3 (es) | 2005-03-01 |
| MX9706826A (es) | 1997-11-29 |
| PE7698A1 (es) | 1998-03-11 |
| YU14196A (sh) | 1999-03-04 |
| DE69632724T2 (de) | 2005-07-07 |
| WO1996028424A1 (en) | 1996-09-19 |
| CA2209904A1 (en) | 1996-09-19 |
| IT1275903B1 (it) | 1997-10-24 |
| BR9607347A (pt) | 1997-12-30 |
| ITMI950491A1 (it) | 1996-09-14 |
| AR002967A1 (es) | 1998-05-27 |
| DE69632724D1 (de) | 2004-07-22 |
| EP0815080A1 (de) | 1998-01-07 |
| SK121397A3 (en) | 1998-02-04 |
| BG101711A (en) | 1998-02-27 |
| CO4700521A1 (es) | 1998-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9607347A (pt) | Esteres e amidas de 1,4-piperidina dissubstítuída possuindo atividade antagonística 5-ht | |
| FI961270A7 (fi) | Takykiniinien antagonisteja ja 3-(5-tetratsolyyli-bentsyyli)amino-piperidiinijohdannaisia | |
| DE69326160D1 (de) | 4-carboxamidopiperidinderivate, zwischenprodukte und verwendung als neurokinin antagonisten | |
| BR9509997A (pt) | Antagonista de taquiquinina | |
| DE69629988D1 (de) | Pharmazeutisches Grundbestandteil und seine Verwendung | |
| FI962489A7 (fi) | Morfoliini-ja tiomoforfoliinitakykiniinireseptoriantaginisteja | |
| FI961239A7 (fi) | 3-amino-5-karboksisubstituoituja piperidiinejä ja 3-amino-5-karboksisubstituoituja pyrrolidiinejä takykiniiantagonisteina | |
| DE69631390D1 (de) | Substituierte Benzylaminpiperidin-Verbindungen | |
| DK0839039T3 (da) | Paroxetinpræparater med styret frigivelse | |
| FI962445L (fi) | Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi | |
| DE69531331D1 (de) | Phenylpiperidinderivate als neurokinin antagonists | |
| NO974602D0 (no) | 1,3-Dihydro-1-(fenylalkyl)-2H-imidazol-2-onderivater med PDE IV- og cytokinaktivitet | |
| IT1284346B1 (it) | Cerniera per mobili | |
| FI972988A0 (fi) | Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä | |
| FI931682A7 (fi) | Tackykiniinireseptoriantagonistit, isokinolonit ja niiden valmistus | |
| KR970006301A (ko) | -피페리딘 또는 테트라하이드로피리딘 아자비사이클로카복스아미드 | |
| KR970015658U (ko) | 모니터 베이스의 체결구조 | |
| KR970042250U (ko) | 가구용 못 | |
| KR970042251U (ko) | 가구용 못 | |
| KR970010676U (ko) | 수직 및 수평기 | |
| KR970007954U (ko) | 가구 수평조절기 | |
| SI0853619T1 (en) | Disubstituted piperidine derivatives | |
| KR970019245U (ko) | 높이 조절형 모니터 | |
| FIU930115U0 (fi) | Med svans foersedd saekerhetsstol foer barn | |
| SE9501299L (sv) | Barriär säng |